Cargando…
ProCPU Is Expressed by (Primary) Human Monocytes and Macrophages and Expression Differs between States of Differentiation and Activation
Carboxypeptidase U (CPU, TAFIa, CPB2) is a potent attenuator of fibrinolysis that is mainly synthesized by the liver as its inactive precursor proCPU. Aside from its antifibrinolytic properties, evidence exists that CPU can modulate inflammation, thereby regulating communication between coagulation...
Autores principales: | Claesen, Karen, De Loose, Joni, Van Wielendaele, Pieter, De bruyn, Emilie, Sim, Yani, Thys, Sofie, De Meester, Ingrid, Hendriks, Dirk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967989/ https://www.ncbi.nlm.nih.gov/pubmed/36835137 http://dx.doi.org/10.3390/ijms24043725 |
Ejemplares similares
-
Pleiotropic Effects of Atorvastatin Result in a Downregulation of the Carboxypeptidase U System (CPU, TAFIa, CPB2) in a Mouse Model of Advanced Atherosclerosis
por: Claesen, Karen, et al.
Publicado: (2021) -
Activation of the Carboxypeptidase U (CPU, TAFIa, CPB2) System in Patients with SARS-CoV-2 Infection Could Contribute to COVID-19 Hypofibrinolytic State and Disease Severity Prognosis
por: Claesen, Karen, et al.
Publicado: (2022) -
Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Disease: What Do We Know Three Decades after Its Discovery?
por: Claesen, Karen, et al.
Publicado: (2021) -
CPU Server
Publicado: (2017) -
In Vitro Evaluation of the Squaramide-Conjugated Fibroblast Activation Protein Inhibitor-Based Agents AAZTA(5).SA.FAPi and DOTA.SA.FAPi
por: Moon, Euy Sung, et al.
Publicado: (2021)